Work

Xihuang pill suppressed primary liver cancer growth by downregulation of AFP and YAP signaling

Year: 2025

Type: article

Source: Journal of Ethnopharmacology

DOI: 10.1016/j.jep.2025.119891

Authors: Sha Luo, Zhen Huang, Yuewen Dai, Shuyang Wang, Wantao Yu, Zhihan Li, Qing Pu, Lihui Yang, Tianyi Yang, Yu Tang, Zhang Wang, Jiabo Wang, Jingxiao Wang

Institutions: Chengdu University of Traditional Chinese Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences, Beijing Fengtai Hospital, Beijing University of Chinese Medicine, Capital Medical University, Second Affiliated Hospital of Xi'an Jiaotong University, Tsinghua University

Language: English

Topic: Hippo pathway signaling and YAP/TAZ

Subfield: Cell Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, China Academy of Chinese Medical Sciences, Beijing Nova Program

Awards: G269452011, G4754906144, G7420267285, G7954999146

OpenAlex ID: W4409841601

FWCI: 1.258

Cites: 46

Cited by: 3

Related to: 10